<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Structural Biology - Most viewed articles</title>
		<link>http://www.biomedcentral.com/bmcstructbiol/mostviewed/</link>
		<description>Most viewed articles in last 30 days from BMC Structural Biology (ISSN 1472-6807) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/21"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/3/6"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/30"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/26"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/25"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/29"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/31"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/17"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/27"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6807/8/6"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/21">
            
            <title>PSAIA &#8211; Protein Structure and Interaction Analyzer</title>
			<description>Background:
PSAIA (Protein Structure and Interaction Analyzer) was developed to compute geometric parameters for large sets of protein structures in order to predict and investigate protein-protein interaction sites.
Results:
In addition to most relevant established algorithms, PSAIA offers a new method PIADA (Protein Interaction Atom Distance Algorithm) for the determination of residue interaction pairs. We found that PIADA produced more satisfactory results than comparable algorithms implemented in PSAIA.Particular advantages of PSAIA include its capacity to combine different methods to detect the locations and types of interactions between residues and its ability, without any further automation steps, to handle large numbers of protein structures and complexes. Generally, the integration of a variety of methods enables PSAIA to offer easier automation of analysis and greater reliability of results.PSAIA can be used either via a graphical user interface or from the command-line. Results are generated in either tabular or XML format.
Conclusion:
In a straightforward fashion and for large sets of protein structures, PSAIA enables the calculation of protein geometric parameters and the determination of location and type for protein-protein interaction sites. XML formatted output enables easy conversion of results to various formats suitable for statistic analysis.Results from smaller data sets demonstrated the influence of geometry on protein interaction sites. Comprehensive analysis of properties of large data sets lead to new information useful in the prediction of protein-protein interaction sites.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/21</link>		
			<dc:creator>Josip Mihel, Mile &#352;iki&#263;, Sanja Tomi&#263;, Branko Jeren and Kristian Vlahovi&#269;ek</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:21</dc:source>
			<dc:subject>Number of accesses: 390</dc:subject>
			<dc:date>2008-04-09</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-21</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-09</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/3/6">
            
            <title>Crystal structural analysis of human serum albumin complexed with hemin and fatty acid</title>
			<description>Background:
Human serum albumin (HSA) is an abundant plasma protein that binds a wide variety of hydrophobic ligands including fatty acids, bilirubin, thyroxine and hemin. Although HSA-heme complexes do not bind oxygen reversibly, it may be possible to develop modified HSA proteins or heme groups that will confer this ability on the complex.
Results:
We present here the crystal structure of a ternary HSA-hemin-myristate complex, formed at a 1:1:4 molar ratio, that contains a single hemin group bound to subdomain IB and myristate bound at six sites. The complex displays a conformation that is intermediate between defatted HSA and HSA-fatty acid complexes; this is likely to be due to low myristate occupancy in the fatty acid binding sites that drive the conformational change. The hemin group is bound within a narrow D-shaped hydrophobic cavity which usually accommodates fatty acid; the hemin propionate groups are coordinated by a triad of basic residues at the pocket entrance. The iron atom in the centre of the hemin is coordinated by Tyr161.
Conclusion:
The structure of the HSA-hemin-myristate complex (PDB ID 1o9x) reveals the key polar and hydrophobic interactions that determine the hemin-binding specificity of HSA. The details of the hemin-binding environment of HSA provide a structural foundation for efforts to modify the protein and/or the heme molecule in order to engineer complexes that have favourable oxygen-binding properties.</description>
			<link>http://www.biomedcentral.com/1472-6807/3/6</link>		
			<dc:creator>Patricia A Zunszain, Jamie Ghuman, Teruyuki Komatsu, Eishun Tsuchida and Stephen Curry</dc:creator>
			<dc:source>BMC Structural Biology 2003, 3:6</dc:source>
			<dc:subject>Number of accesses: 318</dc:subject>
			<dc:date>2003-07-07</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-3-6</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2003-07-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/30">
            
            <title>Graphical analysis of NMR structural quality and interactive contact map of NOE assignments in ARIA</title>
			<description>Background:
The Ambiguous Restraints for Iterative Assignment (ARIA) approach is widely used for NMR structure determination. It is based on simultaneously calculating structures and assigning NOE through an iterative protocol. The final solution consists of a set of conformers and a list of most probable assignments for the input NOE peak list.
Results:
ARIA was extended with a series of graphical tools to facilitate a detailed analysis of the intermediate and final results of the ARIA protocol. These additional features provide (i) an interactive contact map, serving as a tool for the analysis of assignments, and (ii) graphical representations of structure quality scores and restraint statistics. The interactive contact map between residues can be clicked to obtain information about the restraints and their contributions. Profiles of quality scores are plotted along the protein sequence, and contact maps provide information of the agreement with the data on a residue pair level.
Conclusion:
The graphical tools and outputs described here significantly extend the validation and analysis possibilities of NOE assignments given by ARIA as well as the analysis of the quality of the final structure ensemble. These tools are included in the latest version of ARIA, which is available at http://aria.pasteur.fr. The Web site also contains an installation guide, a user manual and example calculations.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/30</link>		
			<dc:creator>Benjamin Bardiaux, Aymeric Bernard, Wolfgang Rieping, Michael Habeck, Th&#233;r&#232;se E Malliavin and Michael Nilges</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:30</dc:source>
			<dc:subject>Number of accesses: 284</dc:subject>
			<dc:date>2008-06-05</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-30</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>30</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/26">
            
            <title>Interactions between the quality control ubiquitin ligase CHIP and ubiquitin conjugating enzymes</title>
			<description>Background:
Ubiquitin (E3) ligases interact with specific ubiquitin conjugating (E2) enzymes to ubiquitinate particular substrate proteins. As the combination of E2 and E3 dictates the type and biological consequence of ubiquitination, it is important to understand the basis of specificity in E2:E3 interactions. The E3 ligase CHIP interacts with Hsp70 and Hsp90 and ubiquitinates client proteins that are chaperoned by these heat shock proteins. CHIP interacts with two types of E2 enzymes, UbcH5 and Ubc13-Uev1a. It is unclear, however, why CHIP binds these E2 enzymes rather than others, and whether CHIP interacts preferentially with UbcH5 or Ubc13-Uev1a, which form different types of polyubiquitin chains.
Results:
The 2.9 &#197; crystal structure of the CHIP U-box domain complexed with UbcH5a shows that CHIP binds to UbcH5 and Ubc13 through similar specificity determinants, including a key S-P-A motif on the E2 enzymes. The determinants make different relative contributions to the overall interactions between CHIP and the two E2 enzymes. CHIP undergoes auto-ubiquitination by UbcH5 but not by Ubc13-Uev1a. Instead, CHIP drives the formation of unanchored polyubiquitin by Ubc13-Uev1a. CHIP also interacts productively with the class III E2 enzyme Ube2e2, in which the UbcH5- and Ubc13-binding specificity determinants are highly conserved.
Conclusion:
The CHIP:UbcH5a structure emphasizes the importance of specificity determinants located on the long loops and central helix of the CHIP U-box, and on the N-terminal helix and loops L4 and L7 of its cognate E2 enzymes. The S-P-A motif and other specificity determinants define the set of cognate E2 enzymes for CHIP, which likely includes several Class III E2 enzymes. CHIP's interactions with UbcH5, Ube2e2 and Ubc13-Uev1a are consistent with the notion that Ubc13-Uev1a may work sequentially with other E2 enzymes to carry out K63-linked polyubiquitination of CHIP substrates.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/26</link>		
			<dc:creator>Zhen Xu, Ekta Kohli, Karl I Devlin, Michael Bold, Jay C Nix and Saurav Misra</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:26</dc:source>
			<dc:subject>Number of accesses: 257</dc:subject>
			<dc:date>2008-05-16</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-26</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>26</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/25">
            
            <title>K2D2: Estimation of protein secondary structure from circular dichroism spectra</title>
			<description>Background:
Circular dichroism spectroscopy is a widely used technique to analyze the secondary structure of proteins in solution. Predictive methods use the circular dichroism spectra from proteins of known tertiary structure to assess the secondary structure contents of a protein with unknown structure given its circular dichroism spectrum.
Results:
We developed K2D2, a method with an associated web server to estimate protein secondary structure from circular dichroism spectra. The method uses a self-organized map of spectra from proteins with known structure to deduce a map of protein secondary structure that is used to do the predictions.
Conclusion:
The K2D2 server is publicly accessible at http://www.ogic.ca/projects/k2d2/. It accepts as input a circular dichroism spectrum and outputs the estimated secondary structure content (alpha-helix and beta-strand) of the corresponding protein, as well as an estimated measure of error.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/25</link>		
			<dc:creator>Carolina Perez-Iratxeta and Miguel A Andrade-Navarro</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:25</dc:source>
			<dc:subject>Number of accesses: 251</dc:subject>
			<dc:date>2008-05-13</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-25</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>25</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-13</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/29">
            
            <title>Protecting role of cosolvents in protein denaturation by SDS: a structural study</title>
			<description>Background:
Recently, we reported a unique approach to preserve the activity of some proteins in the presence of the denaturing agent, Sodium Dodecyl Sulfate (SDS). This was made possible by addition of the amphipathic solvent 2,4-Methyl-2-PentaneDiol (MPD), used as protecting but also as refolding agent for these proteins. Although the persistence of the protein activity in the SDS/MPD mixture was clearly established, preservation of their structure was only speculative until now.
Results:
In this paper, a detailed X-ray study addresses the pending question. Crystals of hen egg-white lysozyme were grown for the first time in the presence of MPD and denaturing concentrations of SDS. Depending on crystallization conditions, tetragonal crystals in complex with either SDS or MPD were collected. The conformation of both structures was very similar to the native lysozyme and the obtained complexes of SDS-lysozyme and MPD-lysozyme give some insights in the interplay of protein-SDS and protein-MPD interactions.
Conclusion:
This study clearly established the preservation of the enzyme structure in a SDS/MPD mixture. It is hypothesized that high concentrations of MPD would change the properties of SDS and lower or avoid interactions between the denaturant and the protein. These structural data therefore support the hypothesis that MPD avoids disruption of the enzyme structure by SDS and can protect proteins from SDS denaturation.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/29</link>		
			<dc:creator>Catherine Michaux, Jenny Pouyez, Johan Wouters and Gilbert G Priv&#233;</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:29</dc:source>
			<dc:subject>Number of accesses: 232</dc:subject>
			<dc:date>2008-06-03</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-29</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>29</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/31">
            
            <title>Systematic analysis of the effect of multiple templates on the accuracy of comparative models of protein structure</title>
			<description>Background:
Although multiple templates are frequently used in comparative modeling, the effect of inclusion of additional template(s) on model accuracy (when compared to that of corresponding single-template based models) is not clear. To address this, we systematically analyze two-template models, the simplest case of multiple-template modeling. For an existing target-template pair (single-template modeling), a two-template based model of the target sequence is constructed by including an additional template without changing the original alignment to measure the effect of the second template on model accuracy. 
Results:
Even though in a large number of cases a two-template model showed higher accuracy than the corresponding one-template model, over the entire dataset only a marginal improvement was observed on average, as there were many cases where no change or the reverse change was observed. The increase in accuracy due to the structural complementarity of the templates increases at higher alignment accuracies. The combination of templates showing the highest potential for improvement is that where both templates share similar and low (less than 30%) sequence identity with the target, as well as low sequence identity with each other. The structural similarity between the templates also helps in identifying template combinations having a higher chance of resulting in an improved model.
Conclusions:
Inclusion of additional template(s) does not necessarily improve model quality, but there are distinct combinations of the two templates, which can be selected a priori, that tend to show improvement in model quality over the single template model. The benefit derived from the structural complementarity is dependent on the accuracy of the modeling alignment. The study helps to explain the observation that a careful selection of templates together with an accurate target:template alignment are necessary to the benefit from using multiple templates in comparative modeling and provides guidelines to maximize the benefit from using multiple templates. This enables formulation of simple template selection rules to rank targets of a protein family in the context of structural genomics.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/31</link>		
			<dc:creator>Suvobrata Chakravarty, Sucheta Godbole, Bing Zhang, Seth Berger and Roberto Sanchez</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:31</dc:source>
			<dc:subject>Number of accesses: 225</dc:subject>
			<dc:date>2008-07-16</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-31</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>31</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/17">
            
            <title>Solution structure of the Legionella pneumophila Mip-rapamycin complex</title>
			<description>Background:
Legionella pneumphila is the causative agent of Legionnaires' disease. A major virulence factor of the pathogen is the homodimeric surface protein Mip. It shows peptidyl-prolyl cis/trans isomerase activty and is a receptor of FK506 and rapamycin, which both inhibit its enzymatic function. Insight into the binding process may be used for the design of novel Mip inhibitors as potential drugs against Legionnaires' disease.
Results:
We have solved the solution structure of free Mip77&#8211;213 and the Mip77&#8211;213-rapamycin complex by NMR spectroscopy. Mip77&#8211;213 showed the typical FKBP-fold and only minor rearrangements upon binding of rapamycin. Apart from the configuration of a flexible hairpin loop, which is partly stabilized upon binding, the solution structure confirms the crystal structure. Comparisons to the structures of free FKBP12 and the FKBP12-rapamycin complex suggested an identical binding mode for both proteins.
Conclusion:
The structural similarity of the Mip-rapamycin and FKBP12-rapamycin complexes suggests that FKBP12 ligands may be promising starting points for the design of novel Mip inhibitors. The search for a novel drug against Legionnaires' disease may therefore benefit from the large variety of known FKBP12 inhibitors.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/17</link>		
			<dc:creator>Andreas Ceymann, Martin Horstmann, Philipp Ehses, Kristian Schweimer, Anne-Katrin Paschke, Michael Steinert and Cornelius Faber</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:17</dc:source>
			<dc:subject>Number of accesses: 224</dc:subject>
			<dc:date>2008-03-17</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-17</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/27">
            
            <title>Prediction of structural stability of short beta-hairpin peptides by molecular dynamics and knowledge-based potentials</title>
			<description>Background:
The structural stability of peptides in solution strongly affects their binding affinities and specificities. Thus, in peptide biotechnology, an increase in the structural stability is often desirable. The present work combines two orthogonal computational techniques, Molecular Dynamics and a knowledge-based potential, for the prediction of structural stability of short peptides (&lt; 20 residues) in solution.
Results:
We tested the new approach on four families of short &#946;-hairpin peptides: TrpZip, MBH, bhpW and EPO, whose structural stabilities have been experimentally measured in previous studies. For all four families, both computational techniques show considerable correlation (r > 0.65) with the experimentally measured stabilities. The consensus of the two techniques shows higher correlation (r > 0.82).
Conclusion:
Our results suggest a prediction scheme that can be used to estimate the relative structural stability within a peptide family. We discuss the applicability of this predictive approach for in-silico screening of combinatorial peptide libraries.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/27</link>		
			<dc:creator>Karin Noy, Nir Kalisman and Chen Keasar</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:27</dc:source>
			<dc:subject>Number of accesses: 216</dc:subject>
			<dc:date>2008-05-29</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-27</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>27</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6807/8/6">
            
            <title>Crystal structures of a purple acid phosphatase, representing different steps of this enzyme's catalytic cycle</title>
			<description>Background:
Purple acid phosphatases belong to the family of binuclear metallohydrolases and are involved in a multitude of biological functions, ranging from bacterial killing and bone metabolism in animals to phosphate uptake in plants. Due to its role in bone resorption purple acid phosphatase has evolved into a promising target for the development of anti-osteoporotic chemotherapeutics. The design of specific and potent inhibitors for this enzyme is aided by detailed knowledge of its reaction mechanism. However, despite considerable effort in the last 10 years various aspects of the basic molecular mechanism of action are still not fully understood.
Results:
Red kidney bean purple acid phosphatase is a heterovalent enzyme with an Fe(III)Zn(II) center in the active site. Two new structures with bound sulfate (2.4 &#197;) and fluoride (2.2 &#197;) provide insight into the pre-catalytic phase of its reaction cycle and phosphorolysis. The sulfate-bound structure illustrates the significance of an extensive hydrogen bonding network in the second coordination sphere in initial substrate binding and orientation prior to hydrolysis. Importantly, both metal ions are five-coordinate in this structure, with only one nucleophilic &#956;-hydroxide present in the metal-bridging position. The fluoride-bound structure provides visual support for an activation mechanism for this &#956;-hydroxide whereby substrate binding induces a shift of this bridging ligand towards the divalent metal ion, thus increasing its nucleophilicity.
Conclusion:
In combination with kinetic, crystallographic and spectroscopic data these structures of red kidney bean purple acid phosphatase facilitate the proposal of a comprehensive eight-step model for the catalytic mechanism of purple acid phosphatases in general.</description>
			<link>http://www.biomedcentral.com/1472-6807/8/6</link>		
			<dc:creator>Gerhard Schenk, Tristan W Elliott, Eleanor Leung, Lyle E Carrington, Nata&#353;a Miti&#263;, Lawrence R Gahan and Luke W Guddat</dc:creator>
			<dc:source>BMC Structural Biology 2008, 8:6</dc:source>
			<dc:subject>Number of accesses: 205</dc:subject>
			<dc:date>2008-01-31</dc:date>
			<dc:identifier>doi:10.1186/1472-6807-8-6</dc:identifier>
			
			
							
					<prism:publicationName>BMC Structural Biology</prism:publicationName>
					
			
							
					<prism:issn>1472-6807</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>6</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
